Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -620.70% is 117% below its 5-year average of -286.68%, near the high end of its 5-year range (-7149.32%–370.58%).
3.94% above its 12-month average of -646.18%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2191.24%.
NET PROFIT MARGIN
-620.70%
NET PROFIT MARGIN AVG TTM
-646.18%
NET PROFIT MARGIN AVG 3Y
-293.80%
NET PROFIT MARGIN AVG 5Y
-286.68%
NET PROFIT MARGIN AVG 10Y
-232.49%
NET PROFIT MARGIN AVG 15Y
-285.88%
NET PROFIT MARGIN AVG 20Y
-297.18%
CURRENT VS TTM AVG
+3.94%
CURRENT VS 3Y AVG
-111.26%
CURRENT VS 5Y AVG
-116.51%
CURRENT VS 10Y AVG
-166.98%
CURRENT VS 15Y AVG
-117.12%
CURRENT VS 20Y AVG
-108.86%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-238630.77%
vs the sector median at left
Cerenome, Inc.
Market Cap
$11.15M
Net Profit Margin
-620.70%
TTM Avg
-646.18%
3Y Avg
-293.80%
5Y Avg
-286.68%
Market Cap
$11.25M
Net Profit Margin
-2702.64%
TTM Avg
-8035.59%
3Y Avg
1817.42%
5Y Avg
219.40%
Market Cap
$11.12M
Net Profit Margin
0.00%
TTM Avg
11.23%
3Y Avg
5.62%
5Y Avg
-9479.86%
Market Cap
$11.82M
Net Profit Margin
-666037.76%
TTM Avg
-148948.78%
3Y Avg
-148948.78%
5Y Avg
-148948.78%
Market Cap
$10.93M
Net Profit Margin
-14621.00%
TTM Avg
-5877.48%
3Y Avg
-2938.74%
5Y Avg
-1959.16%
Market Cap
$11.32M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.06M
Net Profit Margin
-2406.00%
TTM Avg
-2017.47%
3Y Avg
-5077.56%
5Y Avg
-6322.50%
Market Cap
$11.05M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cerenome, Inc. (CNSY) | $11.15M | -620.70% | -646.18% | -293.80% | -286.68% |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.25M | -2702.64% | -8035.59% | 1817.42% | 219.40% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.12M | 0.00% | 11.23% | 5.62% | -9479.86% |
| Caring Brands, Inc. (CABR)vs › | $11.82M | -666037.76% | -148948.78% | -148948.78% | -148948.78% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.93M | -14621.00% | -5877.48% | -2938.74% | -1959.16% |
| BioVie Inc. (BIVI)vs › | $11.09M | 0.00% | 0.00% | 0.00% | 0.00% |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.32M | 0.00% | 0.00% | 0.00% | 0.00% |
| Pluri Inc. (PLUR)vs › | $11.06M | -2406.00% | -2017.47% | -5077.56% | -6322.50% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.05M | 0.00% | 0.00% | 0.00% | 0.00% |
| Biofrontera Inc. (BFRI)vs › | $11.76M | -13.78% | -36.44% | -33.55% | -58.16% |
Operating Margin
-293.5%
Net Profit Margin
-620.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -2191.24% |
| 2026-03-31 | -675.68% |
| 2025-12-31 | -417.92% |
| 2025-09-30 | -316.61% |
| 2025-06-30 | 370.58% |
| 2025-03-31 | -1643.15% |
| 2024-12-31 | -276.42% |
| 2024-09-30 | -197.39% |
| 2024-06-30 | -229.87% |
| 2024-03-31 | -194.45% |
| 2023-12-31 | -290.18% |
| 2023-09-30 | -259.60% |
| 2023-06-30 | -79.94% |
| 2023-03-31 | -949.60% |
| 2022-12-31 | -3747.02% |
| 2022-09-30 | -7149.32% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | -994.05% |
| 2020-03-31 | -921.19% |
| 2019-12-31 | 74.41% |
| 2019-09-30 | 11.02% |
| 2019-06-30 | -3028.81% |
| 2019-03-31 | -218.75% |
| 2018-12-31 | -104.73% |
| 2018-09-30 | -177.59% |
| 2018-06-30 | -234.70% |
| 2018-03-31 | -267.54% |
| 2017-12-31 | -280.56% |
| 2017-09-30 | -271.12% |
| 2017-06-30 | -403.27% |
| 2017-03-31 | -468.86% |
| 2016-12-31 | -162.50% |
| 2016-09-30 | -206.28% |
| 2016-06-30 | -226.73% |
| 2016-03-31 | -182.97% |
| 2015-12-31 | -81.84% |
| 2015-09-30 | 61.65% |
| 2015-06-30 | 128.58% |
| 2015-03-31 | -935.98% |
| 2014-12-31 | -152.72% |
| 2014-09-30 | -850.86% |
| 2014-06-30 | -916.19% |
| 2014-03-31 | -725.24% |
| 2013-12-31 | -290.17% |
| 2013-09-30 | -193.95% |
| 2013-06-30 | -141.64% |
| 2013-03-31 | -204.02% |
| 2012-12-31 | -52.20% |
| 2012-09-30 | -854.71% |
| 2012-06-30 | -180.14% |
| 2012-03-31 | -628.37% |
| 2011-12-31 | -837.21% |
| 2011-09-30 | -389.67% |
| 2011-06-30 | -212.14% |
| 2011-03-31 | -464.84% |
| 2010-12-31 | -351.88% |
| 2010-09-30 | -657.64% |
| 2010-06-30 | -256.29% |
| 2010-03-31 | -55.50% |
| 2009-12-31 | -329.82% |
| 2009-09-30 | -490.76% |
| 2009-06-30 | -9.67% |
| 2009-03-31 | -317.60% |
| 2008-12-31 | 3797.67% |
| 2008-09-30 | -293.84% |
| 2008-06-30 | -599.22% |
| 2008-03-31 | -5407.19% |
| 2007-12-31 | -44500.00% |
| 2007-09-30 | -157.96% |
| 2007-06-30 | -780.47% |
| 2007-03-31 | -3096.07% |
| 2006-12-31 | -27.95% |
| 2006-09-30 | -6591.73% |
| 2006-06-30 | -1614.35% |
| 2006-03-31 | -1485.26% |
| 2005-12-31 | -1989.47% |
| 2005-09-30 | -144.63% |
| 2005-06-30 | -362.34% |
| 2005-03-31 | -257.95% |
| 2004-12-31 | -374.65% |
| 2004-09-30 | 256.26% |
| 2004-06-30 | -247.40% |
| 2004-03-31 | 63.35% |
| 2003-12-31 | -24.05% |
| 2003-09-30 | -62.27% |
| 2003-06-30 | -70.93% |
| 2003-03-31 | -170.04% |
| 2002-12-31 | -268.69% |
| 2002-09-30 | -89.82% |
